John C Reed sold $4.2M of Johnson & Johnson (JNJ)

Executed Oct 17 2025, disclosed Oct 20 2025, 3 days later.

Value, as filed

$4.2M

21,721 sh × $192.71

Executed

Oct 17 2025

the trade date, as filed

Disclosed

Oct 20 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JR John C Reed EVP, Innovative Medicine, R&D profile →

John C Reed (EVP, Innovative Medicine, R&D) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Johnson & Johnson (JNJ). The largest single filing was $13.1M of JNJ (53,931 sh across 3 lots, as filed), executed Feb 17.

The name

JNJ Johnson & Johnson JNJ · Healthcare · 86 filings in 24 months ticker →

Healthcare · Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by John C Reed in JNJ

JNJSALE Johnson & Johnson $13.1M
53,931 sh across 3 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET JNJSALE Johnson & Johnson $3.1M
19,137 sh × $163.55
Exec Jul 17 2025
Filed Jul 18 2025 · 5:30 PM ET